Cargando…
The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma
For decades, no cancer therapy had been shown to improve average survival in metastatic melanoma. Two critical events have occurred, the discovery of melanoma driver mutation subsets and the discovery of immune checkpoint inhibitors, which have allowed for the development of modern, effective therap...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580658/ https://www.ncbi.nlm.nih.gov/pubmed/26387031 http://dx.doi.org/10.1007/s13555-015-0080-7 |